| Labatec Pharma SA - Femoston conti 0.5/2.5, comprimés pelliculés | | 54986 | | 02 | | Femoston conti 0.5/2.5 | | comprimés pelliculés | | G03FA14 | | Dydrogesterone and Estrogen | | 14.03.2011 | | |
| | Composition | | estradiolum 0.5 mg ut estradiolum hemihydricum 0.517 mg, dydrogesteronum 2.5 mg, lactosum monohydricum 117.4 mg, hypromellosum, maydis amylum, silica colloidalis anhydrica, magnesii stearas, pellicule: macrogolum 3350, poly(alcohol vinylicus), talcum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Dydrogesterone | 2.5 mg | | Estradiol | 0.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Dydrogesterone | 2.5 mg | | Estradiol | 0.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | color. | | | | color. | | Hypromellosum | | | | Lactose Monohydrate | 117.4 mg | | | Macrogol | 3350 | pellicule | | | | | | | | | | | | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 28 Tablet(s) | 7.17 | 17.05 | B | SL | No |
|
|
